My watch list
my.chemeurope.com  
Login  

Evonik starts construction of second methionine complex in Singapore

Investment of more than half a billion euros

21-Oct-2016

Evonik Industries AG

Evonik Industries plans to build a second world-scale plant for the production of the amino acid DL-methionine in Singapore are fully on schedule. The company marked the official start of construction with a symbolic ground-breaking ceremony, officiated by Tharman Shanmugaratnam, Singapore Deputy Prime Minister & Coordinating Minister for Economic and Social Policies. The complex will have an annual production capacity of 150,000 metric tons and is expected to become operational in 2019, with investment costs of more than half a billion euros.

“Our methionine complex, which came on-stream in late 2014 on Jurong Island, is a success story. This led to our decision to build a second plant next to it,” said Klaus Engel, the chairman of the Executive Board of Evonik Industries, in Singapore. “The demand for MetAMINO® for animal nutrition is continuing to grow at a very fast rate in Asia." The new plant will not only produce methionine, but also all strategically important precursors to guarantee product quality and supply security.

“Singapore has proven an ideal location for supplying our Asian customers,” said Reiner Beste, chairman of the Board of Management of Evonik Nutrition & Care GmbH. The new complex will create more than 150 jobs at the location.

The new production complex will increase Evonik’s annual capacity of MetAMINO® to a total of approximately 300,000 metric tons in Asia, and to approximately 730,000 metric tons worldwide. The specialty chemicals company produces the amino acid in its world-scale plants in Antwerp (Belgium), Wesseling/Cologne (Germany), Mobile (Alabama, USA), and Singapore.

Facts, background information, dossiers
  • investments
  • animal nutrition
More about Evonik
  • News

    Evonik more robust as strategy takes effect

    Evonik grew again strongly in 2018. Adjusted EBITDA increased 10 percent to €2.6 billion, compared with the previous year. All three chemical segments contributed to profit growth. The earnings forecast, that Evonik had raised after the first half of the year, was achieved despite external ... more

    Evonik agrees to sell its Methacrylates business

    Evonik has signed an agreement to sell its Methacrylates business to Advent International for €3 billion. The selling price (enterprise value) is 8.5 times the business’ EBITDA. The transaction is subject to approval by the authorities in several countries and is expected to close in the th ... more

    Evonik invests in start-ups

    Evonik has launched its second venture capital fund with a volume of €150 million, more than doubling the amount under management to €250 million. The new fund will help secure access to disruptive technologies and innovative business models as well as supporting Evonik’s digital transforma ... more

  • Companies

    Evonik Industries AG

    more

    Evonik Industries AG

    The Business Area Chemicals of Evonik which is active in the attractive field of specialty chemicals, holds top positions world wide. As Germany’s fifth largest power producer, Evonik is market and technology leader in the planning, construction and operation of highly efficient coal-fired ... more

    Evonik Technology & Infrastructure GmbH

    more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE